{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:19:04Z","timestamp":1767140344682,"version":"build-2238731810"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s10072-023-06727-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:49:00Z","timestamp":1679863740000},"page":"2305-2309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the\u00a0review of literature"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9413-3394","authenticated-orcid":false,"given":"Assunta","family":"Trinchillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Luca","family":"Spiezia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Servillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Iacovazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Di Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"6727_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/01.nrl.0000252948.82865.58","volume":"13","author":"A Coban","year":"2007","unstructured":"Coban A et al (2007) Multiple sclerosis\u2013like clinical and magnetic resonance imaging findings in human immunodeficiency virus positive-case. Neurologist 13:154\u2013157. https:\/\/doi.org\/10.1097\/01.nrl.0000252948.82865.58","journal-title":"Neurologist"},{"key":"6727_CR2","doi-asserted-by":"publisher","unstructured":"Pria Anand et al (2018) Multiple sclerosis and HIV: a case of multiple sclerosis-immune reconstitution inflammatory syndrome associated with antiretroviral therapy initiation. Int J STD Aids 1\u20134. https:\/\/doi.org\/10.1177\/0956462418754972","DOI":"10.1177\/0956462418754972"},{"key":"6727_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s13365-014-0288-9","volume":"20","author":"J Chalkley","year":"2014","unstructured":"Chalkley J et al (2014) Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man. J Neurovirol 20:640\u2013643. https:\/\/doi.org\/10.1007\/s13365-014-0288-9","journal-title":"J Neurovirol"},{"key":"6727_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00876-7","author":"I Mainardi","year":"2020","unstructured":"Mainardi I et al (2020) Acquisition of human immunodeficiency virus infection in a patient with multiple sclerosis: could these conditions positively influence each other\u2019s course? J Neurovirol. https:\/\/doi.org\/10.1007\/s13365-020-00876-7","journal-title":"J Neurovirol"},{"key":"6727_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/jnnp-2014-307932","volume":"86","author":"J Gold","year":"2015","unstructured":"Gold J et al (2015) HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J Neurol Neurosurg Psychiatry 86:9\u201312. https:\/\/doi.org\/10.1136\/jnnp-2014-307932","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6727_CR6","doi-asserted-by":"publisher","unstructured":"Marge Cartau et al (2019) Progressive multifocal leukoencephalopathy: current insights. Degener Neurol Neuromusc Dis 9:109\u2013121. https:\/\/doi.org\/10.2147\/DNND.S203405","DOI":"10.2147\/DNND.S203405"},{"key":"6727_CR7","doi-asserted-by":"publisher","first-page":"103995","DOI":"10.1016\/j.msard.2022.103995","volume":"65","author":"Sarah A Morrow","year":"2022","unstructured":"Morrow Sarah A et al (2022) Use of natalizumab in persons with multiple sclerosis: 2022 update. Mult Scler Relat Dis 65:103995. https:\/\/doi.org\/10.1016\/j.msard.2022.103995","journal-title":"Mult Scler Relat Dis"},{"key":"6727_CR8","doi-asserted-by":"publisher","unstructured":"Chandrashekar Bohra et al (2017) Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control 24(4). https:\/\/doi.org\/10.1177\/1073274817729901","DOI":"10.1177\/1073274817729901"},{"key":"6727_CR9","doi-asserted-by":"publisher","unstructured":"Cieron Roe et al (2015) HIV immunodynamics and multiple sclerosis. Journal of NeuroVirology, Inc. https:\/\/doi.org\/10.1007\/s13365-015-0381-8","DOI":"10.1007\/s13365-015-0381-8"},{"key":"6727_CR10","doi-asserted-by":"crossref","unstructured":"Kappos L, O\u2019Connor PW, Polman CH (2013) Clinical effects of natalizumab on multiple sclerosis appear early in treatment course. J Neurol 260(5):1388\u20131395","DOI":"10.1007\/s00415-012-6809-7"},{"issue":"Suppl 3","key":"6727_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10072-010-0349-7","volume":"31","author":"C Florio","year":"2011","unstructured":"Florio C, Maniscalco GT (2011) Improvement of visual acuity in patients with severe visual loss affected by multiple sclerosis treated with natalizumab: a case report. Neurol Sci 31(Suppl 3):325\u2013327. https:\/\/doi.org\/10.1007\/s10072-010-0349-7","journal-title":"Neurol Sci"},{"issue":"16","key":"6727_CR12","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","volume":"68","author":"LJ Balcer","year":"2007","unstructured":"Balcer LJ, Galetta SL, Calabresi PA et al (2007) Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 68(16):1299\u20131304. https:\/\/doi.org\/10.1212\/01.wnl.0000259521.14704.a8","journal-title":"Neurology"},{"issue":"6","key":"6727_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jamaneurol.2021.0627","volume":"78","author":"A Patel","year":"2021","unstructured":"Patel A et al (2021) Progressive multifocal leukoencephalopathy in a patient with progressive multiple sclerosis treated with ocrelizumab monotherapy. JAMA Neur 78(6):736\u2013740. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0627","journal-title":"JAMA Neur"},{"key":"6727_CR14","doi-asserted-by":"publisher","unstructured":"Puig Casadevall M et al (2022) Progressive multifocal encephalopathy in the first patient with relapsing-remitting multiple sclerosis treated with ocrelizumab. Mult Scler J 28(Suppl.): 679\u2013680 abstr. P780, No. 3.\u00a0https:\/\/doi.org\/10.1177\/13524585221123687 [abstract]","DOI":"10.1177\/13524585221123687"},{"issue":"3","key":"6727_CR15","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51130","volume":"8","author":"B Tugemann","year":"2021","unstructured":"Tugemann B, Berger JR (2021) Improving risk-stratification of natalizumab-associated PML. Ann Clin Transl Neurol 8(3):696\u2013703. https:\/\/doi.org\/10.1002\/acn3.51130","journal-title":"Ann Clin Transl Neurol"}],"updated-by":[{"DOI":"10.1007\/s10072-023-06785-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000}}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06727-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06727-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:06:10Z","timestamp":1686355570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06727-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6727"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06727-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"4 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10072-023-06785-x","URL":"https:\/\/doi.org\/10.1007\/s10072-023-06785-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Manuscript has compliance with standards of research involving animals. Manuscript has compliance with standards of research involving humans as subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}